SCHEMBL21591709

SCHEMBL21591709

O=C1CN(C(=O)O)Cc2ccc(Br)cc21

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABHD6 Q9BV23 3/20 0.40
PARP1 P09874 2/20 0.38
TDP1 Q9NUW8 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
PARP10 Q53GL7 1/20 0.38
DPP8 Q6V1X1 1/20 0.38
DPP9 Q86TI2 1/20 0.38
DPP7 Q9UHL4 1/20 0.38
SRD5A1 P18405 1/20 0.37
SRD5A2 P31213 1/20 0.37
EDNRB P24530 1/20 0.36
EDNRA P25101 1/20 0.36
S100A4 P26447 1/20 0.36
METAP1 P53582 1/20 0.36
HSP90AA1 P07900 1/20 0.35
PBRM1 Q86U86 1/20 0.35
BCL2 P10415 1/20 0.35
MCL1 Q07820 1/20 0.35
CA1 P00915 1/20 0.35
CA2 P00918 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29104006 0.87 SRD5A1 (0.44) ABHD6PARP1PARP10DPP8DPP9
SCHEMBL1956852 0.81 ABHD6 (0.55) ABHD6DPP8DPP9DPP7SRD5A1
SCHEMBL4437450 0.81 ABHD6 (0.55) ABHD6DPP8DPP9DPP7SRD5A1
SCHEMBL21591715 0.79 ESR2 (0.51) ABHD6NAMPT
SCHEMBL21800358 0.78 TMEM97 (0.52)
SCHEMBL29375980 0.76 KMT2A (0.46) TDP1L3MBTL1HSP90AA1
SCHEMBL28695007 0.76 KMT2A (0.46) TDP1L3MBTL1HSP90AA1
SCHEMBL23326623 0.75 MAOA (0.49) ABHD6HSP90AA1PBRM1
SCHEMBL15779215 0.75 MEN1 (0.43) PARP1TDP1L3MBTL1PARP10SRD5A1
SCHEMBL18586139 0.72 TDP1 (0.42) PARP1TDP1L3MBTL1PARP10SRD5A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3807270-A1 NOVEL HETEROARYL HETEROCYCLYL COMPOUNDS FOR THE TREATMENT OF AUTOIMMUNE DISEASE F. Hoffmann-La Roche AG (CH) 2021-04-21 EP disclosed
WO-2019238616-A1 NOVEL HETEROARYL HETEROCYCLYL COMPOUNDS FOR THE TREATMENT OF AUTOIMMUNE DISEASE F. HOFFMANN-LA ROCHE AG (CH) 2019-12-19 WO disclosed